UH Seidman Cancer Center — Cleveland, Ohio

UH Seidman Cancer Center is a clinical research site located in Cleveland, Ohio, United States 44106.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

UH Seidman Cancer Center has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: AML, AML With Mutated NPM1, Hematologic Malignancy.

Sponsors: Kura Oncology, Inc., Bayer, Circle Pharma.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UH Seidman Cancer Center?

UH Seidman Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UH Seidman Cancer Center conducted?

UH Seidman Cancer Center has 4 clinical trials on record, with 3 currently active. Their work covers AML, AML With Mutated NPM1, Hematologic Malignancy.

Is UH Seidman Cancer Center accredited by Crixeo Health?

Yes — UH Seidman Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UH Seidman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.